CAY10595 is primarily utilized in research settings as a selective inhibitor of soluble epoxide hydrolase (sEH). This enzyme plays a significant role in the metabolism of epoxyeicosatrienoic acids (EETs), which are involved in various physiological processes, including inflammation, vascular function, and pain regulation. By inhibiting sEH, CAY10595 helps to increase the levels of EETs, thereby promoting their beneficial effects. Researchers use this compound to study the potential therapeutic applications in conditions such as hypertension, chronic pain, and inflammatory diseases. Its ability to modulate these pathways makes it a valuable tool in understanding the underlying mechanisms of these disorders and in the development of targeted treatments.